Literature DB >> 14769901

Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system.

Christopher J McCormick1, Lisa Challinor1, Andrew Macdonald1, David J Rowlands1, Mark Harris1.   

Abstract

We have developed a baculovirus delivery system that enables tetracycline-regulated expression of polII-derived hepatitis C virus (HCV) transcripts in hepatocyte-derived cell lines (McCormick et al., 2002). As part of a study to determine whether such transcripts are replication competent, the transcription start site of the tetracycline-regulable promoter was mapped and three baculovirus transfer vectors containing a neo(R)-expressing culture adapted replicon cDNA were generated. These vectors either had the first nucleotide of the 5'UTR positioned -2 (mkI) and +1 (mkII) with respect to the transcription start site, or included a hammerhead ribozyme at the 5' end of the transcript (5'HH) that cleaves between the ribozyme-5'UTR boundary. Transfection of all of the culture-adapted replicon constructs into Huh7 cells resulted in the formation of more neomycin-resistant colonies than seen with a polymerase knock-out replicon construct, although this was less pronounced in the mkI group. Furthermore, both the positive- and negative-strands of the replicon could be detected in all neomycin-resistant polyclonal cell lines except for those derived from transfection of the polymerase knock-out construct. Transduction of Huh7 cells with recombinant baculoviruses carrying the same expression cassettes improved replicon delivery, but the relative efficiency of the constructs remained the same. The baculovirus vectors were also used to introduce the replicon transcript into HepG2 cells. Expression of the culture-adapted but not the polymerase knock-out construct induced transcription of the beta-interferon gene, a response that may contribute to this cell line being unable to maintain the replicon over long-term culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769901     DOI: 10.1099/vir.0.19676-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

Review 1.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

2.  Translation termination reinitiation between open reading frame 1 (ORF1) and ORF2 enables capsid expression in a bovine norovirus without the need for production of viral subgenomic RNA.

Authors:  Christopher J McCormick; Omar Salim; Paul R Lambden; Ian N Clarke
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Authors:  Adrien Breiman; Nathalie Grandvaux; Rongtuan Lin; Catherine Ottone; Shizuo Akira; Mitsutoshi Yoneyama; Takashi Fujita; John Hiscott; Eliane F Meurs
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Authors:  Baptiste Jammart; Maud Michelet; Eve-Isabelle Pécheur; Romain Parent; Birke Bartosch; Fabien Zoulim; David Durantel
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

6.  Baculovirus mediated production of infectious hepatitis C virus in human hepatoma cells stably expressing T7 RNA polymerase.

Authors:  Xiangjie Yao; Qingxia Han; Jianhua Song; Changyong Liang; Takaji Wakita; Rongge Yang; Xinwen Chen
Journal:  Mol Biotechnol       Date:  2008-06-10       Impact factor: 2.695

7.  Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA.

Authors:  Vernon K Ward; Christopher J McCormick; Ian N Clarke; Omar Salim; Christiane E Wobus; Larissa B Thackray; Herbert W Virgin; Paul R Lambden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

8.  Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription.

Authors:  Andrew Street; Andrew Macdonald; Christopher McCormick; Mark Harris
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Exploiting cis-acting replication elements to direct hepatitis C virus-dependent transgene expression.

Authors:  Jing Zhang; Osamu Yamada; Takashi Sakamoto; Hiroshi Yoshida; Hiromasa Araki; Kunitada Shimotohno
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

10.  A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly.

Authors:  Mair Hughes; Sarah Gretton; Holly Shelton; David D Brown; Christopher J McCormick; Allan G N Angus; Arvind H Patel; Stephen Griffin; Mark Harris
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.